- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05556278
Evaluation of Ecography as a Diagnostic Tool in the Carpal Tunnel Syndrome Compared to the Studies of Electroconduction
September 23, 2022 updated by: Hospital Universitario Virgen Macarena
The main objective is to investigate the value of ultrasound in the diagnosis of Carpal Tunnel Syndrome (CTS), and among the secondary objectives, to establish the ultrasound parameters that are predictors of CTS in comparison with neurophysiological studies, attempting to standardize a protocol and reference values that determine the presence or absence of CTS.
Finally, cost-effectiveness analysis is proposed.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The reference test with which the ultrasound is compared is the neurophysiological test (NPT).
The expected timeline for the study is to be performed between July 2020 and May 2023.
Study Type
Observational
Enrollment (Anticipated)
438
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sevilla, Spain, 41009
- Recruiting
- Hospital Universitario Virgen de la Macarena
-
Contact:
- María de la Paz Murciano Casas, MD
- Phone Number: +34 955 00 80 00
- Email: maripazmurciano@gmail.com
-
Contact:
- Manuel Rodríguez-Piñero Durán, MD
- Phone Number: +34 955 00 80 00
- Email: manuel.rodriguezpinero.sspa@juntadeandalucia.es
-
Sub-Investigator:
- Aguas Santas Jiménez Sarmiento
-
Sub-Investigator:
- Mercedes Álvarez López
-
Sub-Investigator:
- Gema Jiménez Jurado
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with clinical suspicion of CTS that come consecutively from the Neurophysiology Department of the Virgen Macarena Hospital in Seville (Spain).
Description
Inclusion Criteria:
Presenting clinical symptoms suggestive of CTS, at least one of the following:
- Neuropathic profile pain in wrist-hand at the level of the median nerve territory (wrist, first-second-third, and radial half of the fourth finger by palmar and/or volar side), possibility of irradiation of the pain towards the forearm and/or arm.
- Nocturnal symptoms.
- Hypotrophy or atrophy of the thenar eminence.
- Self-described sensory alteration (sensation of cramping, numbness, tingling, hypoalgesia or analgesia).
- Age: 18 to 75 years.
- Consent to participate in the study.
Exclusion Criteria:
- Previous surgery on the wrist
- Acquired or hereditary pathology causing peripheral neuropathies
- Polyneuropathy of any etiology
- Rheumatoid arthritis
- Diabetes Mellitus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intervention
An electroneurography and an ultrasound study will be performed to patients with clinical suspicion of CTS and fulfilling the inclusion/exclusion criteria.
|
based on the recommendations of the American Association of Electrodiagnostic Medicine (AAEM) (1)
ultrasound protocol described by Chen et al. (2)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic variables
Time Frame: January 2021 to September 2022
|
Sex, age, time of evolution of the clinic, manual dominance, hand affected, body mass index, employment status, type of work (pink, white or blue collar), time worked, triggers of symptoms, what symptoms are relieved with, as well as toxic habits, whether they are smokers (to be answered affirmative or negative) or alcohol consumers (to be answered affirmative or negative).
|
January 2021 to September 2022
|
|
Electrodiagnostic variables
Time Frame: January 2021 to September 2022
|
Motor conduction velocity of the median nerve (calculating distal motor latency and wrist-elbow motor conduction velocity), motor conduction velocity of the ulnar nerve (calculating distal motor latency, lower and upper wrist-elbow motor conduction velocity), orthodromic sensory conduction of the median, ulnar and radial nerve, as well as antidromic sensory conduction of the median, ulnar and radial nerve.
|
January 2021 to September 2022
|
|
Ultrasound variables
Time Frame: January 2021 to September 2022
|
The cross-sectional area (CSA), range of median nerve thinning, wrist-forearm index, flexor retinaculum bulge, power Doppler uptake, and existence of notches
|
January 2021 to September 2022
|
|
Boston Carpal Tunnel Questionnaire
Time Frame: January 2021 to September 2022
|
January 2021 to September 2022
|
|
|
Cost evaluation
Time Frame: From September 2022 to May 2023
|
Costs of the consumables established by the Andalusian Health Service used in both tests and the average time for each of the tests
|
From September 2022 to May 2023
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- American Association of Electrodiagnostic Medicine, American Academy of Neurology, and American Academy of Physical Medicine and Rehabilitation. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. Muscle Nerve. 2002 Jun;25(6):918-22. doi: 10.1002/mus.10185. No abstract available.
- Chen YT, Williams L, Zak MJ, Fredericson M. Review of Ultrasonography in the Diagnosis of Carpal Tunnel Syndrome and a Proposed Scanning Protocol. J Ultrasound Med. 2016 Nov;35(11):2311-2324. doi: 10.7863/ultra.15.12014. Epub 2016 Sep 14.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2020
Primary Completion (ANTICIPATED)
October 30, 2022
Study Completion (ANTICIPATED)
May 31, 2023
Study Registration Dates
First Submitted
September 23, 2022
First Submitted That Met QC Criteria
September 23, 2022
First Posted (ACTUAL)
September 27, 2022
Study Record Updates
Last Update Posted (ACTUAL)
September 27, 2022
Last Update Submitted That Met QC Criteria
September 23, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RHB-02/2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The full study protocol can be accessed by contacting the trial team at (e-mail).
Anonymized participants level data and statistical codes used for the analysis are available on request and subject to data sharing agreements.
Data sharing may only be possible after relevant embedded trials have been published.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.